Gilead Sciences (GILD) said on Friday that the European Commission (EC) granted conditional marketing authorization for ...
Effective therapy for NASH is still lacking. In this study, we investigated the effects of Ursodeoxycholic acid (UDCA) in the treatment of NASH. Methods: Western and Chinese databases were ...
Ursodeoxycholic acid aggravates bile infarcts in bile duct-ligated and Mdr2 knockout mice via disruption of cholangioles. Gastroenterology 123 , 1238–1251 (2002). Article CAS PubMed Google Scholar ...
Sciences announced that the European Commission (EC) has granted conditional marketing authorization for seladelpar for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results